Tuberculosis Drug Market Size, Share and Forecast 2026
The Tuberculosis Drug market is expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
(EMAILWIRE.COM, September 12, 2019 ) Market Overview:
Tuberculosis (TB), known as poor mans disease, is caused by Mycobacterium tuberculosis germs that are spread from person to person through the air.
TB usually affects the lungs and affects the other parts of the body such as the brain, the kidneys, or the spine. Across the globe, almost two billion people are infected with M. tuberculosis.
Market Dynamics:
The primary factors driving the Tuberculosis Drug market have increased the incidence of TB in Africa and Asia, Emergence of MDR-TB and XDR-TB strains and Increase in an outbreak of TB-HIV co-infection.The high prevalence of TB in Asia and Africa is driving the TB drug market.
Market Segmentation:
By Therapy Type
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
By Type
Latent TB Type
Active Type
Geographical Analysis:
By Geography, the market is segmented into:
North America
Europe
South America
Asia Pacific
The Middle East and Africa
Competitive Analysis:
Key players:
Pfizer Inc.
Lupin Laboratories Ltd
AstraZeneca
Novartis AG
Cipla Ltd
Others
View full report: https://www.datamintelligence.com/research-report/tuberculosis-drug-market
Download free sample: https://www.datamintelligence.com/download-sample/tuberculosis-drug-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Tuberculosis (TB), known as poor mans disease, is caused by Mycobacterium tuberculosis germs that are spread from person to person through the air.
TB usually affects the lungs and affects the other parts of the body such as the brain, the kidneys, or the spine. Across the globe, almost two billion people are infected with M. tuberculosis.
Market Dynamics:
The primary factors driving the Tuberculosis Drug market have increased the incidence of TB in Africa and Asia, Emergence of MDR-TB and XDR-TB strains and Increase in an outbreak of TB-HIV co-infection.The high prevalence of TB in Asia and Africa is driving the TB drug market.
Market Segmentation:
By Therapy Type
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
By Type
Latent TB Type
Active Type
Geographical Analysis:
By Geography, the market is segmented into:
North America
Europe
South America
Asia Pacific
The Middle East and Africa
Competitive Analysis:
Key players:
Pfizer Inc.
Lupin Laboratories Ltd
AstraZeneca
Novartis AG
Cipla Ltd
Others
View full report: https://www.datamintelligence.com/research-report/tuberculosis-drug-market
Download free sample: https://www.datamintelligence.com/download-sample/tuberculosis-drug-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results